Abstract
Hepatitis B virus (HBV) remains as the viral infection with the highest risk of transmission by transfusion. This risk is associated with window period donations, occult HBV infection (OBI) and the emergence of escape mutants, which render blood donations false negative for hepatitis B surface antigen (HBsAg) serological testing. A retrospective study was conducted to gain insights into the molecular epidemiology of HBV escape mutants in Scottish blood donors. The criterion for selection was HBV positivity either by serology or nucleic acid testing (NAT). HBsAg detection was compared across several commercial immunoassays. The full length S gene from plasma samples was PCR amplified, cloned and expressed in HepG2 cells. Eight samples showed HBsAg discordant results, while 5 OBI samples were found. Four escape mutants, containing missense mutations in the S gene, are described here. These mutations impaired HBsAg detection both from HBV infected plasma samples and from recombinant proteins derived from its infected donors. Phylogenetic analysis showed that most of the mutants were clustered in the genotype D and were closely related to strains from Asia and the Middle East. We report here a proline substitution, outside the major hydrophilic region, that impaired HBsAg detection in vivo and in vitro, warning about the risk for the emergence of vaccine escape mutants with mutations outside the major neutralisation site.
Similar content being viewed by others
References
Brant L, Cawley C, Reynolds C, Byrne L (2008) Infection surveillance annual report 2007. The NHS Blood and Transplant and Health Protection Agency. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1227255714122. Accessed 22 Nov 2012
Brailsford S, Davison K, Reynolds C, Homer K, Vasconcelos M (2011) Safe supplies: new horizons. Annual Review from the NHS Blood and Transplant/Health Protection Agency. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317136707628. Accessed 22 Nov 2012
Allain JP (2004) Occult hepatitis B virus infection: implications in transfusion. Vox Sang 86:83–91
Allain JP, Candotti D (2009) Diagnostic algorithm for HBV safe transfusion. Blood Transfus 7:174–182
Allain JP, Cox L (2011) Challenges in hepatitis B detection among blood donors. Curr Opin Hematol 18:461–466
Cleland A, Nettleton P, Jarvis L, Simmonds P (1999) Use of bovine viral diarrhoea virus as an internal control for amplification of hepatitis C virus. Vox Sang 76:170–174
Jarvis L, Becker J, Tender A, Cleland A, Queiros L, Aquiar A, Azevedo J, Aprili G, Bressan F, Torres P, Nieto S, Ursitti A, Montoro J, Vila E, Ramada C, Saldanha J (2008) Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study. Transfusion 48:1853–1861
Gnaneshan S, Ijaz S, Moran J, Ramsay M, Green J (2007) HepSEQ: international public health repository for hepatitis B. Nucleic Acids Res 35:D367–D370
Kay A, Zoulim F (2007) Hepatitis B virus genetic variability and evolution. Virus Res 127:164–176
Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, Buxton S, Cooper A, Markowitz S, Duran C, Thierer T, Ashton B, Meintjes P, Drummond A (2012) Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28:1647–1649
Ponde RA (2011) The underlying mechanisms for the “isolated positivity for the hepatitis B surface antigen (HBsAg)” serological profile. Med Microbiol Immunol 200:13–22
Persson B, Argos P (1994) Prediction of transmembrane segments in proteins utilising multiple sequence alignments. J Mol Biol 237:182–192
Eble BE, MacRae DR, Lingappa VR, Ganem D (1987) Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen. Mol Cell Biol 7:3591–3601
Blanchet M, Sureau C (2006) Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity. J Virol 80:11935–11945
Zuckerman JN, Zuckerman AJ (2003) Mutations of the surface protein of hepatitis B virus. Antiviral Res 60:75–78
Ma Q, Wang Y (2012) Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen. J Med Virol 84:198–206
Mangold CM, Streeck RE (1993) Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J Virol 67:4588–4597
Huang CH, Yuan Q, Chen PJ, Zhang YL, Chen CR, Zheng QB, Yeh SH, Yu H, Xue Y, Chen YX, Liu PG, Ge SX, Zhang J, Xia NS (2012) Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol 57:720–729
Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M (2006) Characterization of HBV DNA+/HBsAg− blood donors in Poland identified by triplex NAT. Hepatology 44:1666–1674
Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, Decker R, Sanders R (1997) The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 26:1658–1666
Sayiner AA, Agca H, Sengonul A, Celik A, Akarsu M (2007) A new hepatitis B virus vaccine escape mutation in a renal transplant recipient. J Clin Virol 38:157–160
Hsu HY, Chang MH, Ni YH, Chiang CL, Chen HL, Wu JF, Chen PJ (2010) No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. J Infect Dis 201:1192–1200
Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289–309
Salisse J, Sureau C (2009) A function essential to viral entry underlies the hepatitis B virus “a” determinant. J Virol 83:9321–9328
Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC (1990) Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325–329
Kalinina T, Iwanski A, Will H, Sterneck M (2003) Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R. Hepatology 38:1274–1281
Avellon A, Echevarria JM (2006) Frequency of hepatitis B virus ‘a’ determinant variants in unselected Spanish chronic carriers. J Med Virol 78:24–36
Chua PK, Wang RY, Lin MH, Masuda T, Suk FM, Shih C (2005) Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus. J Virol 79:13483–13496
Ito K, Qin Y, Guarnieri M, Garcia T, Kwei K, Mizokami M, Zhang J, Li J, Wands JR, Tong S (2010) Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J Virol 84:12850–12861
Warner N, Locarnini S (2008) The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 48:88–98
Clements CJ, Coghlan B, Creati M, Locarnini S, Tedder RS, Torresi J (2010) Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization? Bull World Health Organ 88:66–73
Scheiblauer H, El-Nageh M, Diaz S, Nick S, Zeichhardt H, Grunert HP, Prince A (2010) Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sang 98:403–414
Bar-Yishay I, Shaul Y, Shlomai A (2011) Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression. Liver Int 31:282–290
Chandra PK, Biswas A, Datta S, Banerjee A, Panigrahi R, Chakrabarti S, De BK, Chakravarty R (2009) Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection. J Viral Hepat 16:749–756
Barclay ST, Cameron S, Mills PR, Priest M, Ross F, Fox R, Goulding C, Forrest EH, Morris AJ, Neilson M, Stanley AJ (2010) The changing face of hepatitis B in greater Glasgow: epidemiological trends 1993–2007. Scott Med J 55:4–7
Mackenzie AR, Molyneaux PJ, Cadwgan AM, Laing RB, Douglas JG, Smith CC (2003) Increasing incidence of acute hepatitis B virus infection referrals to the Aberdeen Infection Unit: a matter for concern. Scott Med J 48:73–75
Acknowledgments
We are very thankful to Helen Munro and Tony Jordan for providing serology results, Jacqui Doran for HBV NAT and all SNBTS teams involved in sample collection and storage.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Larralde, O., Dow, B., Jarvis, L. et al. Hepatitis B escape mutants in Scottish blood donors. Med Microbiol Immunol 202, 207–214 (2013). https://doi.org/10.1007/s00430-012-0283-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00430-012-0283-9